Tepnel's 1st-half 2007 income increases 15%

Tepnel Life Sciences, a UK firm specializing in molecular diagnostics and research products and services, says that its first-half 2007 results demonstrate continued growth and profitability. The firm's revenue jumped to L9.0 million ($18.2 million) from L8.2 million, an increase of 15% on a constant currency basis, while gross profit increased 22% to L5.1 million, with gross margin improving to 56.2% from 50.9% the previous year.

During the period, the Manchester-headquartered company saw a 562% increase in operating profit before exceptional items to L500,000 from L80,000 in 2006, while operating profit increased to L500,000 compared to a loss of L500,000. Earnings before interest, taxes, depreciation and amortization, as well as before items, increased 124% to L770,000 from L350,000. The company added that Tepnel continues to deliver sustained growth in both revenue and operating profit across both of its divisions.